Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [177Lu]Lu-PSMA-617: A Single-Center Retrospective Study

By afschroeder • February 3, 2026

Murthy V, Kimura K, Theus L, Nguyen A, Grogan TR, Lokre O, Perk T, Rettig MB, Drakaki A, Shen J, Thin P, Nguyen K, Lira S, Nabong RM, Gardner L, Gonzalez BD, Gafita A, Czernin J, Calais J. Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [¹⁷⁷Lu]Lu-PSMA-617: A Single-Center Retrospective Study. J Nucl Med. 2026 Feb 2;67(2):246-252. doi: 10.2967/jnumed.125.270916. PMID: 41344853.

Tags: adverse hematologic events, BPI-SF, Cardiology/Epi, DOM STAT, FACT-P, General Internal Medicine, Hematology/Oncology, PSMA RPT, Publications, Veterans Administration, xerostomia

New strategies for valve replacement and interventional options in adults with congenital heart disease: new insights from Euro-ACHD 2025

Butera G, Chessa M, Gaio G, Kempny A, Uebing A, Michielon G, Aboulhosn J, Giamberti A, Hoschtitzky A, d'Udekem Y. New strategies for valve replacement[...]

Navigating the Complexities of Carcinoid Heart Disease and Severe Coronary Artery Disease: A Case for Multidisciplinary Collaboration

Arbit B. Navigating the Complexities of Carcinoid Heart Disease and Severe Coronary Artery Disease: A Case for Multidisciplinary Collaboration. Cureus. 2025 Dec 23;17(12):e99940. doi: 10.7759/cureus.99940.[...]

Residual Risk Despite Quadruple Medical Therapy for Men vs Women Hospitalized for Heart Failure With Reduced Ejection Fraction

Greene SJ, Xu H, Chiswell K, Felker GM, Lewsey SC, Divanji PH, Goertz HP, Heitner SB, Butler J, Fonarow GC. Residual Risk Despite Quadruple Medical[...]